Role Summary
Senior Director, Patient Access Lead to establish and lead a critical function in preparing for the successful launch of lonvo-z, our groundbreaking investigational therapy in phase 3 for hereditary angioedema (HAE). A career-defining opportunity to lead the first commercialization of an in vivo one-time CRISPR-based therapy, building and inspiring high-performing teams while navigating uncharted territory in genetic medicine.
Responsibilities
- Patient Access/ Field Reimbursement Leadership
- Build and lead a high-performing field reimbursement/patient access team to proactively support providers and patients in overcoming access and reimbursement challenges.
- Develop strategic solutions to address coverage, coding, and payment issues related to lonvo-z.
- Work closely with Strategic Account Leads, Payer Account Team, Hub, and case managers to mitigate barriers to access.
- Lead team through center profiling to assess access readiness for activation and launch.
- Work with payers, providers, and patient advocacy groups to ensure lonvo-z is accessible and affordable.
- Contribute to the creation of reimbursement tools, resources, and educational materials to support field teams and provider partners.
- Contribute to the development of patient access manager training materials and onboard the newly created team.
- Access and Stakeholder Engagement
- Serve as the primary liaison with external stakeholders to foster collaboration and address barriers.
- Partner with market access and policy lead to monitor and respond to changes in reimbursement environments and healthcare policies.
- Advocate for patients and providers by addressing challenges related to patient access and site readiness.
- Supervisory Responsibilities
- Team leadership and development: recruit and hire high-caliber talent; manage and mentor the patient access team; set KPIs; provide updates to executive leadership on site readiness and access-related progress.
Qualifications
- Deep understanding of infusion-based therapies, site operations, reimbursement implications, billing & coding, and payer dynamics in the U.S. healthcare system.
- Ability to navigate CGT reimbursement complexities such as single case agreements.
- Proven ability to develop and implement access site readiness strategies and resolve reimbursement challenges.
- Strong leadership skills with experience building and managing high-performing teams.
- Exceptional communication and relationship-building skills across internal teams and external stakeholders.
- Outstanding verbal, written, and interpersonal skills with the ability to influence and build relationships across a diverse stakeholder landscape.
- Results-driven self-starter with accountability and cross-functional collaboration.
- Organized, flexible, and adaptable; comfortable navigating ambiguity and shifting priorities.
- Familiarity with healthcare compliance regulations and payer reimbursement policies.
- Strong problem-solving and analytical skills for complex access and operational challenges.
- Collaborate with HR to attract, hire, develop, and motivate top talent; establish high performance standards.
- Proven track record of establishing new functions and organizational capabilities; budget and resourcing oversight.
- Experience introducing novel approaches to accelerate delivery of innovative therapies.
- Willingness to travel up to 60% to engage with sites, field teams, and stakeholders.
- Bachelorโs degree in life sciences, business, healthcare administration, or related field; Advanced degree preferred (MBA, PharmD).
- 10+ years in access site readiness, field reimbursement, or market access in biopharma/healthcare; 3-5 years in field reimbursement leadership.
- Prior US launch experience required.
- Experience with cell and gene therapy or other highly specialized therapies; experience in competitive rare diseases and HAE preferred.
Education
- Bachelorโs degree in life sciences, business, healthcare administration, or related field. Advanced degree preferred (MBA, PharmD).
Additional Requirements
- Travel up to 60% as needed to engage with sites, field teams, and stakeholders.